Finance

Beta
Lists
0QF:FRA
Moderna Inc
€44,15
+5,81%
(+2,43) 1D
4 ມິ.ຖ., 20 ໂມງ 4 ນາທີ 00 ວິນາທີ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 0QF...
Open
€41,70
High
€44,15
Low
€41,70
Mkt. cap
໒໐,໒໖ ຕື້
Avg. vol.
໑,໓໘ ພັນ
Volume
໑໖໗,໐໐
52-wk high
€50,70
52-wk low
€19,26
No. of employees
໕ ພັນ
Open
€41,70
High
€44,15
Low
€41,70
Mkt. cap
໒໐,໒໖ ຕື້
Avg. vol.
໑,໓໘ ພັນ
Volume
໑໖໗,໐໐
52-wk high
€50,70
52-wk low
€19,26
No. of employees
໕ ພັນ
News stories
From sources across the web
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. Wikipedia
About Moderna Inc
CEOStéphane Bancel
Employees4,7 ພັນ
Foundedກ.ຍ. 2010
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
142,00 ລ້ານ
1,02 ຕື້
678,00 ລ້ານ
389,00 ລ້ານ
Cost of goods sold
819,00 ລ້ານ
1,01 ຕື້
1,23 ຕື້
726,00 ລ້ານ
Cost of revenue
819,00 ລ້ານ
1,01 ຕື້
1,23 ຕື້
726,00 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
230,00 ລ້ານ
268,00 ລ້ານ
308,00 ລ້ານ
173,00 ລ້ານ
Operating expense
230,00 ລ້ານ
268,00 ລ້ານ
308,00 ລ້ານ
173,00 ລ້ານ
Total operating expenses
1,05 ຕື້
1,28 ຕື້
1,54 ຕື້
899,00 ລ້ານ
Operating income
-907,00 ລ້ານ
-260,00 ລ້ານ
-857,00 ລ້ານ
-510,00 ລ້ານ
Other non operating income
9,00 ລ້ານ
-4,00 ລ້ານ
-2,00 ລ້ານ
-
EBT including unusual items
-818,00 ລ້ານ
-187,00 ລ້ານ
-799,00 ລ້ານ
-1,33 ຕື້
EBT excluding unusual items
-818,00 ລ້ານ
-191,00 ລ້ານ
-797,00 ລ້ານ
-455,00 ລ້ານ
Income tax expense
7,00 ລ້ານ
13,00 ລ້ານ
27,00 ລ້ານ
9,00 ລ້ານ
Effective tax rate
-0,86%
-6,95%
-3,38%
-0,67%
Other operating expenses
-
-
-
-
Net income
-825,00 ລ້ານ
-200,00 ລ້ານ
-826,00 ລ້ານ
-1,34 ຕື້
Net profit margin
-580,99%
-19,68%
-121,83%
-345,24%
Earnings per share
-2,13
-0,51
-2,11
-1,18
Interest and investment income
81,00 ລ້ານ
73,00 ລ້ານ
70,00 ລ້ານ
72,00 ລ້ານ
Interest expense
-1,00 ລ້ານ
-
-8,00 ລ້ານ
-17,00 ລ້ານ
Net interest expenses
80,00 ລ້ານ
73,00 ລ້ານ
62,00 ລ້ານ
55,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-850,00 ລ້ານ
-208,00 ລ້ານ
-790,00 ລ້ານ
-451,00 ລ້ານ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more